UBR7 and breast cancer: Collectively, our results demonstrated that UBR7 is a H2B E3 ubiquitin ligase that suppresses triple-negative subtype of breast cancer by activating CDH4/R-cadherin expression and inhibiting the canonical Wnt/β-catenin signaling pathway.